Spencer Ryan's Insider Trades & SAST Disclosures
Spencer Ryan's most recent trade in Dynavax Technologies Corp. was a trade of 55,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Spencer Ryan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 55,000 | 110,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 55,000 | 297,261 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.93 per share. | 18 Feb 2025 | 36,528 | 260,733 (0%) | 0% | 12.9 | 472,307 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 136,000 | 136,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 62,500 | 273,522 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 62,500 | 62,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 62,500 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.69 per share. | 13 Feb 2025 | 31,694 | 242,261 (0%) | 0% | 12.7 | 402,197 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 20,833 | 222,231 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 20,833 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 10 Feb 2025 | 11,209 | 211,022 (0%) | 0% | 13.2 | 147,959 | Common Stock |
| Cidara Therapeutics Inc | Ryan Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Ryan Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 4,250 | 4,250 | - | - | Stock Option (right to buy) | |
| Dynavax Technologies Corp. | Spencer Ryan | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 231,000 | 231,000 | - | - | Stock Options (Right to Buy) | |
| Dynavax Technologies Corp. | Spencer Ryan | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 165,000 | 165,000 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Spencer Ryan | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 9.45 per share. | 15 Feb 2024 | 402 | 201,030 (0%) | 0% | 9.5 | 3,799 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 20,833 | 20,833 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 20,833 | 212,312 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. | 10 Feb 2024 | 11,684 | 200,628 (0%) | 0% | 12.8 | 149,789 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 29,750 | 193,132 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 29,750 | 29,750 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 20,834 | 174,019 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 20,834 | 41,666 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 14,673 | 178,459 (0%) | 0% | 10.4 | 152,012 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 10,637 | 163,382 (0%) | 0% | 10.4 | 110,199 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 9,888 | 157,855 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 4,670 | 153,185 (0%) | 0% | 10.4 | 48,381 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 9.73 per share. | 16 Feb 2023 | 1,786 | 147,967 (0%) | 0% | 9.7 | 17,378 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 16 Feb 2023 | 1,668 | 146,181 (0%) | 0% | 10.3 | 17,164 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 9,888 | 9,888 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 29,663 | 9,887 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 29,663 | 159,434 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Sale of securities on an exchange or to another person at price $ 16.92 per share. | 08 Aug 2022 | 14,921 | 144,513 (0%) | 0% | 16.9 | 252,399 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 89,250 | 160,839 (0%) | 0% | 0 | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 89,250 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 62,500 | 62,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 10 Feb 2022 | 1,969 | 71,589 (0%) | 0% | 3.4 | 6,675 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 20,833 | 20,833 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 20,833 | 80,411 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.60 per share. | 22 Feb 2021 | 10,791 | 69,620 (0%) | 0% | 9.6 | 103,594 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 22 Feb 2021 | 1,519 | 59,578 (0%) | 0% | 3.4 | 5,149 | Common Stock |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 89,250 | 89,250 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 04 Feb 2021 | 1,518 | 58,059 (0%) | 0% | 3.4 | 5,146 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges